Accueil>>Natural Products>>Theaflavin-3'-gallate

Theaflavin-3'-gallate (Synonyms: TF2A, Theaflavin Monogallate A)

Catalog No.GC37778

La théaflavine-3'-gallate, un monomère de théaflavine du thé noir, est considérée comme le composant actif biologiquement important du thé noir et offre des bienfaits pour la santé. Le gallate de théaflavine-3' agit comme pro-oxydant et induit un stress oxydatif dans les cellules du carcinome. Le gallate de théaflavine-3' réagit directement avec le glutathion réduit (GSH) en fonction du temps et de la concentration.

Products are for research use only. Not for human use. We do not sell to patients.

Theaflavin-3'-gallate Chemical Structure

Cas No.: 28543-07-9

Taille Prix Stock Qté
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Theaflavin-3'-gallate, a black tea theaflavin monomer, is regarded as the biologically important active component of black tea and provides health benefits. Theaflavin-3'-gallate acts as prooxidants and induces oxidative stress in the carcinoma cells. Theaflavin-3'-gallate reacts directly with reduced glutathione (GSH) in a time- and concentration-dependent manner[1].

[1]. Babich H, et al. Theaflavin-3-gallate and theaflavin-3'-gallate, polyphenols in black tea with prooxidant properties. Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):66-74.

Avis

Review for Theaflavin-3'-gallate

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Theaflavin-3'-gallate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.